Randomized phase II trial of Budesonide Turbuhaler 800 micrograms/twice daily versus placebo in high-risk population with undetermined lung nodules detected at screening low dose CT [computed tomography] scan.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Budesonide (Primary)
- Indications Lung cancer
- Focus Biomarker; Therapeutic Use
- 25 Jan 2016 Biomarkers information updated
- 04 Nov 2011 Actual end date (Sep 2011) added as reported by ClinicalTrials.gov.
- 04 Nov 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.